SOX9 Antikörper
Kurzübersicht für SOX9 Antikörper (ABIN7384338)
Target
Alle SOX9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Affinity Purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:1000-1:2000 IHC 1:20-1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 300 μg/mL
-
Buffer
- 50 mM Tris-Glycine( pH 7.4), 0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Andere Bezeichnung
- SOX9
-
Hintergrund
- Campomelic dysplasia autosomal sex reversal,CMD 1,CMD1,CMPD 1,CMPD1,SOX 9,Sox9,SOX9,SRA 1,SRA1,SRXX2,SRXY10,SRY (sex determining region Y) box 9 (campomelic dysplasia autosomal,SRY (sex determining region Y) box 9,SRY (sex determining region Y)-box 9,SRY (sex-determining region Y)-box 9 protein,SRY related HMG box gene 9,Transcription factor SOX 9,Transcription factor SOX-9,transcription factor SOX9,The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.
-
Molekulargewicht
-
Observed_MW: 70kDa
Calculated_MW: 56kDa
-
Gen-ID
- 6662
-
UniProt
- P48436
-
Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
Target
-